HER2+ Metastatic Breast Cancer: Safety Data With T-DXd
Homing in on trastuzumab deruxtecan, T-DXd, expert panelists review recent safety data in the setting of HER2+ metastatic breast cancer.
Read More
Overview of Treatment Options in HER2+ Metastatic Breast Cancer
Shared insight on the treatment armamentarium for patients diagnosed with HER2+ metastatic breast cancer.
Read More
Escalation or Deescalation of Therapy in Early-Stage HER2+ Breast Cancer
Before closing out their discussion on early-stage HER2+ breast cancer, expert oncologists define the value of escalating or deescalating therapy.
Read More
Early-Stage HER2+ Breast Cancer: Novel Perioperative Treatment Strategies
Subject matter experts in breast oncology discuss ongoing clinical trials in early-stage HER2+ breast cancer that focus on perioperative therapies.
Read More
Establishing the Role of Neratinib Therapy in Early-Stage HER2+ Breast Cancer
Expert oncologists share their perspectives on when it would be appropriate to consider neratinib therapy in early-stage HER2+ breast cancer.
Read More
Role of Multidisciplinary Team in the Management of Patients with HER2+ BC and CNS Metastases
July 8th 2022Highlighting the importance of a multidisciplinary approach to care in HER2+ mBC, Vijayakrishna Gadi, MD, PhD, describes the value of effective consultation with neurooncologists and radiation oncologists for CNS metastases.
Read More
Early Stage HER2+ Breast Cancer: Optimizing Use of T-DM1
A brief discussion on the role of trastuzumab emtansine, T-DM1, in patients with early-stage HER2+ breast cancer.
Read More
Subcutaneous HP Therapy in Early-Stage HER2+ Breast Cancer
Panelists review clinical data behind subcutaneous HP therapy in early stage HER2+ breast cancer and elucidate the real-world use of this approach.
Read More
Selecting and Sequencing Therapy in Patients with HER2+ mBC and CNS Metastases
July 1st 2022An expert oncologist reviews key considerations in selecting and sequencing treatment appropriately in patients with HER2+ breast cancer and CNS metastases, including challenges associated with treating leptomeningeal disease.
Read More
HER2 Dual Blockade in Early Stage HER2+ Breast Cancer
Shared insight on the optimal use of HER2 dual-blockade strategies in patients with early stage HER2+ breast cancer.
Read More
Early Stage HER2+ Breast Cancer: Overview of Adjuvant Treatment
Expert oncologists review adjuvant treatment strategies in early stage HER2+ breast cancer and consider when observation alone would be appropriate.
Read More